Format

Send to

Choose Destination
Biol Blood Marrow Transplant. 2016 Aug;22(8):1348-1356. doi: 10.1016/j.bbmt.2016.04.018. Epub 2016 Apr 27.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Author information

1
Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota. Electronic address: custun@umn.edu.
2
Division of Hematology, Stanford University, Stanford, California.
3
Department of Stem Cell Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
4
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
5
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Minneapolis, Minnesota.
6
Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany.
7
Department of Hematology/Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California.
8
Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
9
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
10
Department of Hematology, Oregon Health and Science University, Portland, Oregon.
11
Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
12
Department of Pathology, University of New Mexico, Albuquerque, New Mexico.
13
Division of Hematology and Oncology, Weill Cornell Medical College, New York, New York.
14
Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
15
Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
16
Division of Hematology, Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
17
Division of Hematology, Istanbul Medical School, University of Istanbul, Istanbul, Turkey.
18
Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
19
Department of Medicine, Weill Cornell Medical College, New York, New York.
20
Division of Hematology, Department of Medical Sciences Uppsala University, Uppsala, Sweden.
21
Department of Hematology, Hematology Institute, University Hospital, School of Medicine, University of Basse-Normandie, Caen, France.
22
Cellular and Molecular Oncology Unit, CNRS UMR 8113, Ecole Normale Supériede Cachan, Cachan, France and Laboratoire d'Hématologie, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France.
23
Institut für Pathologie der LMU, Munchen, Germany.
24
Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
25
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, University of Washington, Seattle, Washington.
26
Division of Hematology, Department of Medicine, Ohio State University and the Ohio State University Comprehensive Cancer Center, Ohio.
27
Division of Rheumatology, Immunology, and Allergy, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
PMID:
27131865
DOI:
10.1016/j.bbmt.2016.04.018
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center